Gerresheimer stock falls 1.5 percent as margins weaken

Published on 09/24/2026 at 15:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Gerresheimer stock traded at EUR 26.28 on September 24, 2026, while Q1 revenue reached EUR 524 million. Adjusted EBITDA fell to EUR 66 million from EUR 81 million.

Automatisierte Glasampullen-Produktionslinie in steriler Pharmafabrik — Gerresheimer AG mit ISIN DE000A0LD6E6 produziert Glasampullen in hochautomatisierter, steriler Pharmaverpackungsfertigung mit modernster Anlagentechnik, Illustration mit AI erstellt.

Gerresheimer stock (ISIN DE000A0LD6E6) was trading at EUR 26.28 on Xetra on September 24, 2026, down 1.50 percent from the prior close of EUR 26.68. The investor-relations calendar lists Barclays and Jefferies events for September 24, 2026, giving the market a fresh checkpoint on the packaging group's restructuring and financing plans.

Revenue edges higher in Q1

According to finanzen.ch in Gerresheimer's August 27, 2026 release, Q1 2026 revenue reached EUR 524 million, compared with EUR 519 million in Q1 2025. That is an increase of EUR 5 million, or 1.0 percent, showing that sales held up even as profitability weakened.

The same release reported adjusted EBITDA of EUR 66 million, down from EUR 81 million in the prior-year quarter. The decline of EUR 15 million cut the adjusted EBITDA margin to 12.6 percent from 15.7 percent, a 3.1 percentage-point reduction.

Cash flow shapes the investor debate

The Q1 release emphasized free cash flow and the planned disposal of Centor and Primary Packaging Plastics to strengthen the balance sheet. The operating picture is therefore split: revenue rose 1.0 percent, while adjusted EBITDA fell 18.5 percent year over year.

Gerresheimer's official investor calendar also lists its Q1 quarterly communication for September 2026 and a half-year financial report for November 2026, according to the Gerresheimer investor-relations page. These dates matter because the next figures must show whether the margin pressure is easing.

Stock trades below yearly high

Gerresheimer stock was trading at EUR 26.28 on Xetra on September 24, 2026, with a market capitalization of EUR 907.71 million. The 52-week range was EUR 14.83 to EUR 42.92, leaving the share EUR 16.64 below its yearly high while the Q1 revenue comparison remains positive.